Author: OurCrowd

[Alloy Therapeutics in Business Wire] Alloy Therapeutics announces scientific advisory board to drive roadmap of biotherapeutic discovery platform innovation

Sep 20, 2023 |

BOSTON–(BUSINESS WIRE)–Alloy Therapeutics, a biotechnology ecosystem company, announced the formation of its scientific advisory board (SAB) that includes a group of renowned experts in fields spanning immunology, protein engineering, T cell receptor (TCR) modalities, and more. Alloy’s SAB members have been instrumental in developing Alloy’s technical roadmap as the company has developed cutting edge technologies and services across antibodies, bispecifics, TCRs and TCR mimics, genetic medicines, cell therapies, peptides and drug delivery technologies. Read...

Read More

[InsideTracker in PR Newswire] InsideTracker unveils 10 new healthspan-focused DNA insights, fast-tracking the path to optimal health and longevity

Sep 20, 2023 |

CAMBRIDGE, Mass, Sept. 20, 2023 /PRNewswire/ — InsideTracker, the leading personalized health analysis and data-driven wellness guide that helps people live healthier longer, has unveiled 10 new healthspan-focused DNA insights, focused on optimizing the customers healthspan journey. When purchased in combination with InsideTracker’s Ultimate Plan, the DNA Kit now offers up to 38 genetic assessments. Read more...

Read More